Main > A1. CORP. INDEX. Nn-Nz > Novo Nordisk /P C2
This data is not available for free
Novo Nordisk /P C2's subsections
2000. 07.10.2000. (Indl. Enzymes)
2002. 03.15.2002. (Collaboration)
2002. 09.02.2002. (Collaboration)
2002. 12.02.2002. (Metabonomics)
2002. 12.16.2002. (Diab.)
2003. 11.18.2003. (Collaboration)
2006. 03.14.2006. (Nephrology)
2006. 03.15.2006. (Nastech Pharma.)
2007. 01.22.2007. CSO & Exec VP
2007. 02.21.2007. TransTech Pharma
2007. 03.12.2007. Backs R&D In CN
2007. 04.02.2007. Pres.
2007. 11.19.2007. (Diab.)
2008. 03.06.2008. (USA>Hq.>NJ)
2008. 05.05.2008. Donates Molecule
2008. 05.13.2008. Blood Coag.
2008. 05.15.2008. Diab.
2008. 09.18.2008. IP Acq From Neose
2009. 07.03.2009. Diab>GLP-1 EU
2009. 12.08.2009. IL-21 MAb
2010. 01.26.2010. Diab>GLP-1 USA
2012. 01.24.2012. Diab>R&D>USA
2012. 05.09.2012. VP Reg Affairs
2012. 05.22.2012. Diab>Pediatrics
2012. 06.21.2012. Diab>Semaglutide
2012. 09.24.2012. Invests in CN
2012. 09.28.2012. Haemophilia
2013. 01.04.2013. Corp. VP & Gen.
2013. 02.10.2013. Insulin Degl/Asp.
2013. 10.07. Insulin Tab.
2013. 10.16. Haemophilia A
2013. 12.23. Rare Bleeding Dis.
2014. 12.23. Diab>Obesity
2015. 08.27. Acq. Calibrium & MB2
2015. 09.07. MIT Langer Lab.
2015. 09.25. Insulin Degl
2017. 01.30. Uni. Oxford
2017. 03.27. Insulin Aspart
2017. 05.31. Hemophilia B
2018. 05.23. Diabetic Nephropathy
2018. 08.17. Acq. Ziylo Ltd
2019. 02.19. Haemophilia A USA>OK
2019. 06.20. Haemophilia A EU>OK
2019. 07.12. Haemophilia A CA>OK
2019. 09.20. Diab.>Semaglutide TABs
2020. 01.06. Diab.>insulin aspart i
2020. 01.16. CV Risk Redn.
2020. 06.11. Acq. Corvidia ..
2020. 11.06. Acq. Emisphere Tech.
2020. 12.05. Obesity>Liraglutide
2021. 06.04. Obesity>Semaglutide
2021. 11.18. Acq. Dicerna Pharma.
2021. 12.28. Acq. Dicerna Pharma.
2022. 01.17. EraCal Therapeutics
2022. 03.28. Diab-2>Semaglutide 2 m
2022. 09.01. Acq. Forma Therapeutic
2023. 08.10. Acq. InverSago Pharma
2023. 10.02. Rare DISs.>PH1>USA>OK
2023. 10.16. KBP Biosciences
2024. 03.08. USA Approval
2024. 03.25. Acq. Cardior Pharma
2024. 12.20. USA Approval
2025. 05.14. Septerna
2025. 05.14. Septerna
Novo Nordisk Biotech Fund C2
Novo Nordisk Brazil C2
Novo Nordisk Inc./P C2
Patents
Web-Site
Z - OK
Novo Nordisk /P C2's products
This section has no products